Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.

O Ciofu, B Giwercman, J Walter-Rasmussen, T Pressler, S S Pedersen, N Høiby

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.'. Together they form a unique fingerprint.

Medicine & Life Sciences